Clinical Comparison of a Novel Balloon-Expandable Versus a Self-Expanding Transcatheter Heart Valve for the Treatment of Patients with Severe Aortic Valve Stenosis: The EVAL Registry.
Monica BarkiAlfonso IelasiAndrea BuonoGabriele MaliandiMariano PellicanoMarta BandeFrancesco CasilliFrancesca MessinaGiuseppe UccelloDaniele BrigugliaMassimo MeddaMaurizio TespiliFrancesco DonatelliPublished in: Journal of clinical medicine (2022)
In patients with severe symptomatic AS undergoing TAVR, the novel Myval BE THV provided a comparable performance to the well-known ER SE THV, and it was associated with a lower rate of PPI and ≥moderate PVL within 30 days and 6 months after the procedure. Randomized, head-to-head comparison trials are needed to confirm our results.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- early onset
- double blind
- open label
- high intensity
- randomized controlled trial
- clinical trial
- placebo controlled
- phase iii
- atrial fibrillation
- phase ii
- small molecule
- combination therapy
- study protocol